help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on April 16, 2009, doi:10.1165/rcmb.2008-0228OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2008-0228OCv1
42/2/210    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Wong, P. S.
Right arrow Articles by Matsumura, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, P. S.
Right arrow Articles by Matsumura, F.
American Journal of Respiratory Cell and Molecular Biology. Vol. 42, pp. 210-217, 2010
© 2010 American Thoracic Society
DOI: 10.1165/rcmb.2008-0228OC

Arylhydrocarbon Receptor Activation in NCI-H441 Cells and C57BL/6 Mice

Possible Mechanisms for Lung Dysfunction

Patrick S. Wong1,2, Chris F. Vogel1,2, Katherine Kokosinski1,2 and Fumio Matsumura1,2

1 Center for Health and the Environment, and 2 Department of Environmental Toxicology, University of California at Davis, Davis, California

Correspondence and requests for reprints should be addressed to Patrick S. Wong, Ph.D., Center for Health and the Environment, University of California at Davis, 1 Shields Avenue, Davis, CA 95616. E-mail: patwong{at}ucdavis.edu

The arylhydrocarbon receptor (AhR) is known for its ability to bind aromatic-containing compounds, which starts a molecular cascade involving the induction of cytochrome P450s and inflammatory cytokines. Our hypothesis is that many inhaled environmental toxicant components activate these inflammatory pathways via an initial binding to the AhR. To test this possibility, we treated Clara cell–derived NCI-H441 cells with the AhR agonist, 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD), and demonstrated that AhR activation increased the expression of both cytochrome P450 s and inflammatory markers. We also found increased mucin 5AC production with TCDD treatment. Similar results were observed in NCI-H441 cells treated with urban dust particles. Mucin 5AC expression was highly correlated with increased-expression cyclooxygenase-2 and IL-1β, thus implicating these two inflammatory markers as possible conduits for AhR-mediated mucin production. We hypothesize that this increase in mucin 5AC production is a result of inflammation-induced differentiation of our epithelial cell to a mucin-producing cell. This theory is supported by morphological changes observed in the cells, as well as decreased expression of Clara cell secretory protein (CC10). In an in vivo C57BL/6 mouse model, TCDD increased expression of inflammatory cytokines, mucin 5AC, and a number of matrix metalloproteases in whole-lung samples. These changes were not seen in mice in which AhR signaling was repressed. These markers from the whole-lung samples have been correlated to onset of bronchitis, asthma, small airways disease, and fibrosis, and their increased expression further implicates AhR activation in producing the molecular environment for the development of lung injury to occur.

Key Words: arylhydrocarbon receptor • 2,3,7,8-tetrachlordibenzo-p-dioxin • mucin • air pollution







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2010 American Thoracic Society.
  New Orleans Int'l Conf